CollPlant Biotechnologies Cash Flow Statement
NASDAQ: OPHIHealth CareIndustrial SpecialtiesUSD
3.13-0.08 (-2.49%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CollPlant Biotechnologies free cash flow
In fiscal 2025, CollPlant Biotechnologies generated -$9.4 million of operating cash flow and spent $28,000 on capital expenditures. That left free cash flow of -$9.4 million, a free-cash-flow margin of -398.4% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
CollPlant Biotechnologies cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -11.49M | -16.61M | -7.02M | -16.93M | 237.00K | -5.77M | 11.16M | -6.25M | -6.05M |
| Net Income growth (YoY) | — | — | — | -7241.35% | — | -151.72% | — | — | — |
| Depreciation & Amortization | 912.00K | 1.04M | 1.10M | 1.08M | 773.00K | 660.00K | 539.00K | 342.00K | 230.00K |
| Stock-Based Compensation | 999.00K | 1.72M | 1.94M | 2.17M | 1.60M | 1.67M | 1.13M | 1.43M | 956.00K |
| Change in Working Capital | 426.00K | 671.00K | 1.13M | 477.00K | 1.20M | -1.12M | 247.00K | -1.15M | — |
| Operating Cash Flow | -9.42M | -14.09M | -2.76M | -13.70M | 2.50M | -4.45M | -5.70M | -1.22M | -4.97M |
| Capital Expenditures | -28.00K | -483.00K | -954.00K | -1.27M | -1.43M | -437.00K | -1.49M | -832.00K | -127.00K |
| Investing Cash Flow | -27.00K | -539.00K | -1.16M | 28.92M | -31.56M | -519.00K | -1.46M | -832.00K | -127.00K |
| Debt Issued | — | — | — | — | — | — | — | 58.00K | — |
| Debt Repaid | — | — | — | — | — | -24.00K | -20.00K | -12.00K | -70.00K |
| Financing Cash Flow | 3.10M | 9.00K | 1.11M | 1.87M | 38.76M | 4.46M | 5.41M | 2.75M | 9.11M |
| Net Change in Cash | -6.32M | -14.77M | -3.19M | 16.49M | 9.85M | -445.00K | -1.75M | 704.00K | 4.01M |
| Free Cash Flow | -9.45M | -14.58M | -3.72M | -14.97M | 1.07M | -4.89M | -7.19M | -2.05M | -5.09M |
This table shows 9 annual periods of CollPlant Biotechnologies's cash flow statement, from FY 2025 back to FY 2017, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OPHI's reporting calendar. What is a cash flow statement?